Sound bite for Twitter is: Dividend Paying Financial. Results of stock price testing is that the stock price is on the expensive side. Debt Ratios could certainly due with an improvement in the ratios. The Dividend Payout Ratios (DPR) are probably fine. The current dividend yield is low with dividend growth restarting. See my spreadsheet on
Brookfield Corp.
Is it a good company at a reasonable price? I have always thought that this company was overly complex and they also keep re-organizing. So, this has not been a stock I wanted to invest in. However, I must admit shareholders have done well in total returns over the years by investing in this company. Even though lots of analysts are giving this a Strong Buy rating, the 12 month stock price is less than 1% above the current price. This is rather inconsistent to me. My testing is showing that the stock price is on the expensive side.
I do not own this stock of Brookfield Corp (TSX-BN, NYSE-BN). I used to own an earlier version of this stock as Hees International, then Edper Group and then EdperBrascan back in 1987 to 1999.
When I was updating my spreadsheet, I noticed that few sites are giving estimates for this company for 2025 and beyond. The sites that are giving things like EPS has values that make no sense at all. The other thing to mention is that the company just did, in October 2025, a Stock Split of 3 shares for every 2 shares. There was also a recent dividend cut in 2023.
This company I have always find rather annoying to review. It is always complex. I do not like overly complex reports from companies because it becomes too easy to miss something important. They also keep reorganizing their companies. However, I must admit that this company has had good returns for investors.
If you had invested in this company in December 2014, for $1,007.34 you would have bought 73 shares at $13.80 per share. In December 2024, after 10 years you would have received $809.31 in dividends. The stock would be worth $4,020.84. Your total return would have been $4,380.15. This would be a total return of 18.27% per year with 14.85% from capital gain and 3.43% from dividends. This calculation takes into consideration stock splits, which means that the original cost would be lowered by these splits. Dividends are also high because of a special dividend in 2022. This is in CDN$.
| Cost |
Tot. Cost |
Shares |
Years |
Dividends |
Stock Val |
Tot Ret |
| $13.80 |
$1,007.34 |
73 |
10 |
$809.31 |
$4,020.84 |
$4,830.15 |
The current dividend yield is low with dividend growth restarting. The current dividend yield is low (below 2%) at 0.54%. The 5 and 10 year median dividend yields are low at 1.32% and 1.69%. The historical median dividend yield is moderate (2% to 4%) at 2.15%. Dividends were cut by 50% in 2023. In 2024 they started to raise the dividend rate again. The dividend is still 35% below the 2022 dividend rate. I have dividend information covering the last 37 years and dividends decreased in 8 years in that period.
The Dividend Payout Ratios (DPR) are probably fine. The DPR for 2024 for Earnings per Share (EPS) is much too high at 103% with 5 year coverage fine at 49.8%. The DPR for 2024 for Distributable Earnings (DE) is good at 8% with 5 year coverage at 13%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 4% with 5 year coverage at 7%. The DPR for 2024 for Free Cash Flow (FCF) is non-calculable currently at 21% with 5 year coverage high at 75%. FCF varies from $1,188M to a negative $7,102M.
| Item |
Cur |
5 Years |
| EPS |
103.16% |
49.80% |
| DE |
8.08% |
13.04% |
| CFPS |
4.43% |
6.53% |
| FCF |
-19.33% |
74.50% |
Debt Ratios could certainly due with an improvement in the ratios. The Long Term Debt/Market Cap Ratio for 2024 is too much too high at 2.71 and currently at 2.49. However, we need also to look at the Long Term Debt/Covering Assets Ratio for 2024 which is still too high at 1.04 and currently at 1.07 because this is a more important ratio for a Financial. The Covering Assets Ratio is better than the Market Cap Ratio, but it is still too high. The Liquidity Ratio for 2024 is fine at 1.43 and 1.50 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.54 and currently at 1.66. The Debt Ratio for 2024 is good at 1.51 and 1.68 currently. The Leverage and Debt/Equity Ratios for 2024 are fine at 2.97 and 1.97 and currently too high at 3.13 and 2.13.
| Type |
Year End |
Ratio Curr |
| Lg Term /A |
1.04 |
1.07 |
| Lg Term R |
2.71 |
2.49 |
| Intang/GW |
0.83 |
0.78 |
| Liquidity |
1.43 |
1.50 |
| Liq. + CF |
1.54 |
1.66 |
| Debt Ratio |
1.51 |
1.47 |
| Leverage |
2.97 |
3.13 |
| D/E Ratio |
1.97 |
2.13 |
The Total Return per year is shown below for years of 5 to 37 to the end of 2024 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From |
Years |
Div. Gth |
Tot Ret |
Cap Gain |
Div. |
| 2018 |
5 |
-3.65% |
21.00% |
15.60% |
5.40% |
| 2013 |
10 |
3.54% |
18.27% |
14.85% |
3.43% |
| 2008 |
15 |
4.36% |
20.28% |
16.54% |
3.74% |
| 2003 |
20 |
6.49% |
16.42% |
13.28% |
3.14% |
| 1998 |
25 |
5.22% |
20.38% |
16.02% |
4.36% |
| 1993 |
30 |
4.33% |
19.84% |
14.95% |
4.89% |
| 1988 |
35 |
3.82% |
12.20% |
9.83% |
2.38% |
| 1987 |
37 |
4.44% |
13.49% |
10.54% |
2.96% |
The Total Return per year is shown below for years of 5 to 37 to the end of 2024 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From |
Years |
Div. Gth |
Tot Ret |
Cap Gain |
Div. |
| 2018 |
5 |
-5.60% |
19.67% |
14.11% |
5.55% |
| 2013 |
10 |
1.34% |
15.75% |
12.42% |
3.34% |
| 2008 |
15 |
2.19% |
17.92% |
14.15% |
3.76% |
| 2003 |
20 |
5.55% |
15.81% |
12.37% |
3.44% |
| 1998 |
25 |
5.32% |
21.66% |
16.40% |
5.26% |
| 1993 |
30 |
4.24% |
20.12% |
14.85% |
5.26% |
| 1988 |
35 |
3.18% |
11.52% |
9.15% |
2.37% |
| 1987 |
37 |
4.16% |
13.42% |
10.24% |
3.18% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are 25.94, 33.68 and 41.43. The corresponding 10 year ratios are 13.27, 16.39 and 19.51. The corresponding historical ratios are 9.49, 11.92 and 14.37. The current P/E Ratio is 129.32 based on EPS estimate for 2025 of $0.35 and a stock price of $44.83. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. (This is because of low EPS expected, but this EPS is 68% above the EPS for 2024.) This testing is in US$.
I have Distributable Earnings (DE) data which has been given by the company for the past 8 years. The 5-year low, median, and high median Price/Distributable Earnings Ratios are 9.45, 11.02 and 13.29. The corresponding 8 year ratios are 9.61, 12.47 and 14.89. The current ratio is 17.70 based on a stock price of $44.83 and DE estimate for 2025 of $2.53. The current ratio is above the high ratio for the 8 year median ratios. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
I get a Graham Price of $62.92. The 10-year low, median, and high median Price/Graham Price Ratios are 0.81, 1.03 and 1.29. The current P/GP Ratio is 2.89 based on a stock price of $62.92. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. This testing is in CDN$.
I get a 10-year median Price/Book Value per Share Ratio of 1.22. The current P/B Ratio is 1.45 based on Book Value of $88,215M, Book Value per Share of $30.90 and a stock price of $44.83. The current ratio is 18% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median. This testing is in US$.
I picked up a Book Value per Share estimate for 2025 of $12.55. Since this is 146% below the current Book Value per Share, I wonder how valid it is. Therefore, I am not using this in my testing.
I get a 10-year median Price/Cash Flow per Share Ratio of 7.51. The current ratio is 10.40 based on Cash Flow per Share estimate for 2025 of $4.31, Cash Flow of $9,669M and a stock price of $44.83. The current ratio is 38% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This CFPS estimate is 50% above the CFPS for 2025, so I wonder about it. However, the stock would still not pass this test if the estimate were lower. This testing is in US$.
I get an historical median dividend yield of 2.15%. The current dividend yield is .54% based on dividends of 0.24 and a stock price of $44.83. The current dividend yield is 75% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
I get a 10 year median dividend yield of 1.69%. The current dividend yield is .54% based on dividends of 0.24 and a stock price of $44.83. The current dividend yield is 68% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
The 10-year median Price/Sales (Revenue) Ratio is 0.70. The current ratio is 132 based on Revenue for the last 12 months of $76,076M, Revenue per Share of $33.91 and a stock price of $44.83. The current ratio is 88% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
The estimate given for Revenue for 2025 is $9,474M which make no sense as it is 89% below the Revenue for 20240. I used instead the Revenue for the 12 months ending at the second quarter of 2025.
Results of stock price testing is that the stock price is on the expensive side. I did the testing in US$ because this company reports in US$ and the estimates are also in US$. Dividends have been recently cut in 2023. This makes the dividend test not a good one, but it is never good when I company cuts the dividends. The P/S Ratio test says that the stock price is expensive. In fact, all the testing is pointing to an expensive stock price except the P/B Ratio test which says it is reasonable, but above the median.
When I look at analysts’ recommendations, I find Strong Buy (4), Buy (5), Hold (1) and Sell (1). The consensus would be a Buy. The 12 month stock price consensus is $63.08 ($45.06 US$) with a high of $76.54 ($54.67 US$) and low of $37.84 ($27.30 US$). The consensus stock price of $63.08 implies a total return of 0.79% with 0.26% from capital gains and 0.53% from dividends based on a current stock price of $62.92. This is in CDN$.
There are various opinions from analysts on
Stock Chase from Buy and Top Pick to Do Not Buy for 2025. One analyst, with a Do Not Buy, says it is complexity on steroids and it is really hard to understand what it’s doing. My thoughts exactly. Kay Ng
Motley Fool says you can build real wealth with this stock. Andrew Button on
Motley Fool says the stock is fast rising, but still a good buy. The company put out a
Press Release about their fourth quarter of 2024. The company put out a
Press Release about their second quarter of 2025.
Simply Wall Street via
Yahoo Finance gives a review of this stock. They said that it is undervalued compared to it s Fair Value, but might be overvalued compared to the P/E Ratio. Simply Wall Street shows three warnings of interest payments are not well covered by earnings; earnings have declined by 17.8% per year over past 5 years; and significant insider selling over the past 3 months.
Brookfield Corporation is focused on deploying its capital on a value basis and compounding it over the long term. This capital is allocated across core pillars of asset management, insurance solutions, and our operating businesses. Brookfield Corporation, formerly known as Brookfield Asset Management Ltd., is based in Toronto, Canada. Its web site is here
Brookfield Corp.
The last stock I wrote about was about was Molson Coors Canada (TSX-TPX.B, NYSE-TAP) ...
learn more. The next stock I will write about will be CCL Industries Inc (TSX-CCL.B, OTC-CCDBF) ...
learn more on Monday, October 20, 2025 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these
blog entries and for
stocks followed. I have three blogs. The first talks only about specific stocks and is called
Investment Talk. The second one contains information on mostly investing and is called
Investing Economics Mostly. My last blog is for my book reviews and it is called
Non-Fiction Mostly. Follow me on
Twitter. I am on
Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.